0001

Yuhan Corporation (000100)

Market Closed
18 Jun, 06:30
KRX SM KRX SM
103,700. 00
-1,000
-0.96%
7.56T Market Cap
- P/E Ratio
1,800% Div Yield
245,925 Volume
1,193.51 Eps
104,700
Previous Close
Day Range
103,500 105,300
Year Range
74,700 166,900
Earnings results expected in 38 days

Summary

000100 closed Wednesday lower at ₩103,700, a decrease of 0.96% from Tuesday's close, completing a monthly decrease of -1.14% or ₩1,200. Over the past 12 months, 000100 stock lost -17.11%.
000100 is not paying dividends to its shareholders.
The last earnings report, released on Apr 28, 2025, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0%, based on the last three reports. The next scheduled earnings report is due on Jul 28, 2025.
Yuhan Corporation has completed 5 stock splits, with the recent split occurring on Dec 27, 2023.
The company's stock is traded on 2 different exchanges and in various currencies, with the primary listing on KRX SM (KRW).
Want to track 000100 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

000100 Chart

Yuhan Corporation (000100) FAQ

What is the stock price today?

The current price is ₩103,700.00.

On which exchange is it traded?

Yuhan Corporation is listed on KRX SM.

What is its stock symbol?

The ticker symbol is 000100.

Does it pay dividends? What is the current yield?

It does not pay dividends to its shareholders.

What is its market cap?

As of today, the market cap is 7.56T.

What is the earnings per share?

The EPS is 0.

When is the next earnings date?

The next earnings report will release on Jul 28, 2025.

Has Yuhan Corporation ever had a stock split?

Yuhan Corporation had 5 splits and the recent split was on Dec 27, 2023.

Yuhan Corporation Profile

Drug Manufacturers - Specialty & Generic Industry
Healthcare Sector
Mr. Wook-Je Cho CEO
KRX SM Exchange
KR7000100008 ISIN
KR Country
2,038 Employees
- Last Dividend
27 Dec 2023 Last Split
21 Sep 2012 IPO Date

Overview

Yuhan Corporation, established in 1926, stands as a distinguished entity in the pharmaceutical sector, both in South Korea and on a global scale. Its corporate headquarters are situated in Seoul, South Korea, a testament to its rich heritage and foundational roots within the country's pharmaceutical industry. The organization is deeply involved in a myriad of activities ranging from the research and development (R&D) to the manufacturing and international distribution of pharmaceutical products and intermediates. This extensive involvement has earmarked Yuhan Corporation as a multifaceted company that not only explores the depths of pharmaceutical innovations but also ensures the widespread availability of high-quality medical solutions across the world. Yuhan's commitment to healthcare excellence is reflected in their comprehensive array of product offerings, which cater to various medical needs and conditions, bolstering their reputation as a leading pharmaceutical company.

Products and Services

Yuhan Corporation offers a vast portfolio of products and services designed to meet the healthcare needs of patients worldwide. Below are key highlights from their offerings:

  • Active Pharmaceutical Ingredients (APIs): Including antivirals, antibiotics, antihistamines, antidiabetics, beta-lactamase inhibitors, CNS intermediates, and PEGylated compounds. These APIs form the cornerstone of numerous medications, offering diverse therapeutic benefits.
  • Revanex: Specifically formulated as an acid pump antagonist, Revanex is prescribed for the treatment of peptic ulcers and gastritis-related mucosal injuries, showcasing Yuhan's commitment to addressing gastrointestinal disorders.
  • ETC Products: The company's ETC (Ethical Pharmaceuticals) product line spans across various therapeutic categories, including cardiovascular, alimentary, genito-urinary, metabolic, respiratory and allergy, neuro systems, anti-infective, anti-cancer, hormone therapies, and more. Each category is filled with innovative solutions tailored to patient needs.
  • OTC Products: Yuhan's over-the-counter offerings feature vitamins and minerals, hepatopathy drugs and tonics, respiratory system drugs, alimentary system drugs, and dermatology and analgesics drugs, ensuring accessible healthcare solutions without the need for a prescription.
  • Veterinary Drugs: The company extends its expertise to the veterinary field, providing a range of drugs and feeds aimed at improving the health and well-being of animals, demonstrating Yuhan's holistic approach to healthcare.
  • Household and Healthcare Products: Beyond pharmaceuticals, Yuhan Corporation manufactures and markets a variety of household and healthcare products, articulating its diversification into everyday health and wellness solutions.
  • Dental Care Products: Catering to oral health, the company offers a selection of dental care products, advocating for comprehensive healthcare that includes oral hygiene.
  • Contract Manufacturing Services: Yuhan Corporation provides contract manufacturing services, leveraging its extensive R&D and manufacturing capabilities to offer customized and high-quality manufacturing solutions to partners worldwide.

Contact Information

Address: 74, Noryangjin-ro, Seoul, South Korea
Phone: 82 2 828 0181